UNITE Study: Understanding New Interventions With GBM ThErapy

Stopped The study was terminated because clinical development of depatuxizumab mafodotin in glioblastoma was stopped due to lack of survival benefit.

Conditions

• Glioblastoma Multiforme

Interventions

• DRUG: Steroid eye drops
• DRUG: Vasoconstrictor eye drops
• OTHER: Cold compress
• DRUG: Ophthalmic steroid ointment
• DRUG: Depatuxizumab mafodotin
• DRUG: Temozolomide
• RADIATION: Radiation

Sponsor

AbbVie